Summary & Overview
HCPCS Level II J1786: Injection, imiglucerase, 10 units
HCPCS Level II code J1786 denotes a 10-unit injection of imiglucerase, an enzyme replacement therapy used in treating lysosomal storage disorders such as Gaucher disease. Nationally, biologic infusion and injection codes like J1786 are significant due to high unit costs, site-of-service variability, and payer coverage considerations that affect patient access and provider reimbursement. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on what J1786 represents clinically, where the service is typically delivered, and which major payers are addressed. The publication summarizes common billing modifiers and operational considerations, outlines typical service lines and settings for administration, and highlights benchmarking and policy themes relevant to high-cost injectable biologics. If specific payer policy details, ICD-10 pairings, or taxonomy mappings are needed, the reader will be directed to payer policy documents or claims data resources because those specifics are not included in the input. This summary is intended for national audiences including billing professionals, specialty pharmacy administrators, and health policy analysts seeking a clear, practical overview of HCPCS Level II code J1786.
Billing Code Overview
HCPCS Level II code J1786 represents an injection of imiglucerase, 10 units. This code describes a biologic enzyme replacement therapy administered by injection. The service type is therapeutic infusion/injection, typically delivered in outpatient infusion centers, hospital outpatient departments, specialty clinics, or other settings equipped for parenteral biologic administration.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 35-year-old patient with confirmed Gaucher disease presents to an infusion center for enzyme replacement therapy. The patient receives intravenous imiglucerase dosed per body weight; the billing unit J1786 represents 10 units of imiglucerase. Typical workflow: physician documents diagnosis and orders the weight-based dose; pharmacy prepares the calculated number of 10-unit vials or units and verifies product and lot; nursing obtains informed consent, verifies identity and allergies, establishes IV access, administers premedications if indicated, and infuses imiglucerase according to institution protocol while monitoring vital signs and infusion reactions. Post-infusion, nursing documents volume infused, units administered (number of J1786 units), lot numbers, any reactions, and disposition. Billing captures the number of J1786 units delivered, appropriate place-of-service, and applicable modifier(s) for payer adjudication.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no special circumstances apply to the service |